FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)
Pepaxto Update [2/23/2024] Today, FDA announced its final decision to withdraw approval of Pepaxto (melphalan...
FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
[7/28/2021] FDA is alerting patients and Health care professionals that a clinical trial (OCEAN, Study...